Xvivo Perfusion AB (publ) (XVIVO)’in fiyatı nedir?

Xvivo Perfusion AB (publ) (XVIVO)’in fiyatı $30.43’dir

Xvivo Perfusion AB (publ) (XVIVO)’in piyasa değeri nedir?

Xvivo Perfusion AB (publ) (XVIVO)’in piyasa değeri $958.38M’dir.

Xvivo Perfusion AB (publ) (XVIVO) Fiyat Geçmişi

Xvivo Perfusion AB (publ) is a medical technology company that creates and supplies advanced solutions for the preservation and perfusion of organs, tissues, and cells, primarily for use in transplantation. The company's global reach extends across Sweden, the United States, both North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. Its product line includes the XVIVO System (XPS), an integrated, ready-to-use cardiac bypass system designed to facilitate safe normothermic ex vivo lung perfusion (EVLP). To support this, the XPS Disposable Lung Kit offers all the necessary sterile, pre-packed components for EVLP procedures. Xvivo also provides STEEN Solution, an optimally formulated buffered extracellular solution specifically for perfusing isolated donor lungs during EVLP. Additional offerings comprise Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte preservation solution, and the XVIVO Silicone Tubing Set, used for efficient flushing of donor lungs during the procurement process. The company also manufactures the XVIVO LS and XVIVO Disposable Lung Set, both critical devices for EVLP. Furthermore, Xvivo provides the XVIVO Organ Chamber, a sterile, single-use disposable container for temporarily housing isolated lungs before transplantation, and the XVIVO Lung Cannula Set, another sterile, single-use disposable medical product. Established in 1998, Xvivo Perfusion AB (publ) is headquartered in Gothenburg, Sweden.

Yıl	Performans
2026 (TTM)	24.30%
2025	-54.32%
2024	47.50%
2023	58.97%
2022	-37.57%
2021	-21.09%
2020	109.04%
2019	16.25%
2018	38.58%
2017	12.67%
2016	43.64%
2015	33.79%
2014	1.65%
2013	61.13%
2012	0.00%

Yıl

Performans

2026 (TTM)

24.30%

2025

-54.32%

2024

47.50%

2023

58.97%

2022

-37.57%

2021

-21.09%

2020

109.04%

2019

16.25%

2018

38.58%

2017

12.67%

2016

43.64%

2015

33.79%

2014

1.65%

2013

61.13%

2012

0.00%

Şirket	Hisse fiyatı	Değişim 1yıl%	Ülke
Abbott Laboratories ABT.US	$112.64	-15.09%	US
Stryker Corporation SYK.US	$331.44	-15.32%	US
Medtronic plc MDT.US	$91.30	-1.63%	IE
Boston Scientific Corporation BSX.US	$46.83	-55.61%	US
Siemens Healthineers AG SHL.DE	$46.88	-15.20%	DE

Şirket

Hisse fiyatı

Değişim 1yıl%

Ülke